Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gaudernack

Showing results (131-140 of 152) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute|October 19, 1988
Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantationG Kvalheim, S Funderud, S Kvaløy, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 8, 2010
Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorptionK Szczepanowicz, H J Hoel, L Szyk-Warszynska, et al.
International Journal of Cancer|August 15, 1994
A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?B Fossum, J Breivik, G I Meling, et al.
Scandinavian Journal of Immunology|March 17, 2009
Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cellsE Stronen, I W Abrahamsen, G Gaudernack, et al.
Experimental Dermatology|May 31, 2001
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvantR E Hunger, C U Brand, M Streit, et al.
British Journal of Cancer|August 23, 2000
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancerA Fosså, R Siebert, H C Aasheim, et al.
British Journal of Cancer|September 2, 2005
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patientsL J Mu, J A Kyte, G Kvalheim, et al.
Scandinavian Journal of Immunology|September 3, 2011
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times dailyD Torfoss, B Sandstad, T E Mollnes, et al.
European Journal of Immunology|February 17, 1998
CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeletonA M Rasmussen, V Horejsí, F O Levy, et al.
Cancer Gene Therapy|May 20, 2006
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNAJ A Kyte, L Mu, S Aamdal, et al.
Pageof 16

Showing results (131-140 of 152) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|October 19, 1988
Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantationG Kvalheim, S Funderud, S Kvaløy, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|July 8, 2010
Formation of biocompatible nanocapsules with emulsion core and pegylated shell by polyelectrolyte multilayer adsorptionK Szczepanowicz, H J Hoel, L Szyk-Warszynska, et al.
International Journal of Cancer|August 15, 1994
A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?B Fossum, J Breivik, G I Meling, et al.
Scandinavian Journal of Immunology|March 17, 2009
Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cellsE Stronen, I W Abrahamsen, G Gaudernack, et al.
Experimental Dermatology|May 31, 2001
Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvantR E Hunger, C U Brand, M Streit, et al.
British Journal of Cancer|August 23, 2000
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancerA Fosså, R Siebert, H C Aasheim, et al.
British Journal of Cancer|September 2, 2005
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patientsL J Mu, J A Kyte, G Kvalheim, et al.
Scandinavian Journal of Immunology|September 3, 2011
The mild inflammatory response in febrile neutropenic lymphoma patients with low risk of complications is more pronounced in patients receiving tobramycin once daily compared with three times dailyD Torfoss, B Sandstad, T E Mollnes, et al.
European Journal of Immunology|February 17, 1998
CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeletonA M Rasmussen, V Horejsí, F O Levy, et al.
Cancer Gene Therapy|May 20, 2006
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNAJ A Kyte, L Mu, S Aamdal, et al.
Pageof 16